On the recordMarch 29, 2023
PBMs benefit significantly from high list prices and have no incentive to choose lower-priced drugs to drive down patient costs.
Source
congress.govPBMs benefit significantly from high list prices and have no incentive to choose lower-priced drugs to drive down patient costs.
Menendez critiques PBMs for profiting from high drug prices.
Share
More from Bob Menendez Jr.
Could expanding the scope of hazardous materials subject to increased safety regulations prevent future tragedies like the one in East Palestine?
It was an act of intimidation. It was an act of intimidation not just to the mayor, not just to us, but to everyone watching.
Thank you to our witnesses today for their testimonies, which provide an honest and sobering insight into the state of rail safety today in America.
I thank the FAA for their participation in this workshop. I look forward to continuing to work with you on putting an end to this problem.